KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Invested Capital (2018 - 2024)

BioNTech SE's Invested Capital history spans 7 years, with the latest figure at $1.5 billion for Q4 2024.

  • For Q4 2024, Invested Capital rose 245.27% year-over-year to $1.5 billion; the TTM value through Dec 2021 reached $15.3 billion, up 605.13%, while the annual FY2024 figure was $1.6 billion, 247.84% up from the prior year.
  • Invested Capital for Q4 2024 was $1.5 billion at BioNTech SE, up from $446.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $15.3 billion in Q4 2021 and bottomed at $446.7 million in Q4 2023.
  • The 5-year median for Invested Capital is $1.5 billion (2024), against an average of $4.1 billion.
  • The largest annual shift saw Invested Capital surged 605.13% in 2021 before it crashed 94.76% in 2022.
  • A 5-year view of Invested Capital shows it stood at $2.2 billion in 2020, then soared by 605.13% to $15.3 billion in 2021, then plummeted by 94.76% to $801.0 million in 2022, then tumbled by 44.23% to $446.7 million in 2023, then skyrocketed by 245.27% to $1.5 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Invested Capital are $1.5 billion (Q4 2024), $446.7 million (Q4 2023), and $801.0 million (Q4 2022).